Publications for Johan Rosell
Co-author map based on ISI articles 2007-

Publications mentioned in social media 44 times*

Keywords

urinary tumour trial treatment tamoxifen t1 survival stage risk recurrence radiotherapy prostate progression population-based patients median death carcinoma cancer bladder

Journal Articles

Georg Jancke, Johan Rosell and Staffan Jahnson
  Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer
  SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48(3), 276-283.

Vera Loorents, Johan Rosell, Charlott Karlsson, Maria Lidback, Kristina Hultman and Sussanne Börjeson
  Prophylactic training for the prevention of radiotherapy-induced trismus - a randomised study
  Acta Oncologica, 2014, 53(4), 530-538.
   Fulltext  PDF  

Rune Sjödahl, Johan Rosell and Hans Starkhammar
  Causes of death after surgery for colon cancer-impact of other diseases, urgent admittance, and gender
  Scandinavian Journal of Gastroenterology, 2013, 48(10), 1160-1165.

Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per-Olof Malmstrom, Arne Wallgren, Olle Stål and John Carstensen
  Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
 
Altmetric usage: 2

  Breast Cancer Research and Treatment, 2013, 138(2), 467-473.
 Web of Science® Times Cited: 2

Hans Olsson, Peter Söderkvist, Per Hultman, Johan Rosell and Staffan Jahnson
  MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
  BMC Urology, 2013, 13(5), .
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Hans Olsson, Per Hultman, Johan Rosell and Staffan Jahnson
  Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours
  Scandinavian Journal of Urology and Nephrology, 2013, 47(3), 188-195.
 Web of Science® Times Cited: 1

Annika Malmström, Bjorn Henning Gronberg, Christine Marosi, Roger Stupp, Didier Frappaz, Henrik Schultz, Ufuk Abacioglu, Bjorn Tavelin, Benoit Lhermitte, Monika E Hegi, Johan Rosell and Roger Henriksson
  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
 
Altmetric usage: 10

  The Lancet Oncology, 2012, 13(9), 916-926.
 Web of Science® Times Cited: 137

Hans Olsson, Per Hultman, Nastaran Monsef, Johan Rosell and Staffan Johanson
  Immunohistochemical Evaluation of Cell Cycle Regulators: Impact on Predicting Prognosis in Stage T1 Urinary Bladder Cancer
  ISRN Urology, 2012, 2012, .
   Fulltext  PDF  

Georg Jancke, Johan Rosell and Staffan Jahnson
  Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer
  Scandinavian Journal of Urology and Nephrology, 2012, 46(5), 343-347.
 Web of Science® Times Cited: 4

Georg Jancke, Johan Rosell, Gunilla Chebil and Staffan Jahnson
  Bladder Wash Cytology at Diagnosis of Ta-T1 Bladder Cancer Is Predictive for Recurrence and Progression
  Urology, 2012, 80(3), 625-631.
 Web of Science® Times Cited: 1

Annika Malmström, Roger Stupp, Monika Hegi, Johan Rosell and Roger Henriksson
  Treatment options in elderly patients with glioblastoma - Authors' reply
  The Lancet Oncology, 2012, 13(11), E461-E462.

Yang-mei Shen, Gunnar Arbman, Per Sandström, Per Gullstrand, Yu-Quan Wei, Hong Zhang, Johan Rosell, Birgit Olsson, Feng Peng, Han-Shuo Yang, Chun-Ting Wang and Xiao-Feng Sun
  Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients
  Oncology Reports, 2012, 27(2), 376-382.
 Web of Science® Times Cited: 3

Georg Jancke, Johan Rosell and Staffan Jahnson
  Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder
  Scandinavian Journal of Urology and Nephrology, 2011, 45(6), 388-392.
 Web of Science® Times Cited: 4

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Letter: PROSTATE CANCER SCREENING Authors reply
  BMJ. British Medical Journal, 2011, 342, .

Laszlo Tabar, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell, Helena Fohlin, Robert A Smith and Stephen W Duffy
  Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
 
Altmetric usage: 19

  Radiology, 2011, 260(3), 658-663.
 Web of Science® Times Cited: 117

Jasmine Loof, Johan Rosell, Charlotte Bratthall, Siv Doré, Hans Starkhammar, Hong Zhang and Xiao-Feng Sun
  Impact of PINCH expression on survival in colorectal cancer patients
  BMC CANCER, 2011, 11(103), .
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Randomised prostate cancer screening trial: 20 year follow-up
 
Altmetric usage: 12

  BRITISH MEDICAL JOURNAL, 2011, 342(d1539), .
   Fulltext  PDF  
 Web of Science® Times Cited: 51

Johan Rosell, Bo Nordenskjöld, N-O Bengtsson, T Fornander, T Hatschek, H Lindman, P-O Malmstrom, A Wallgren, Olle Stål and John Carstensen
  Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
  British Journal of Cancer, 2011, 104(6), 899-902.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Staffan Jahnson, Ole Damm, Sverker Hellsten, Sten Holmang, Fredrik Liedberg, Borje Ljungberg, Per-Uno Malmstrom, Wiking Mansson, Johan Rosell and Hans Wijkstom
  Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden
  SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44(2), 69-75.
 Web of Science® Times Cited: 4

Georg Jancke, Ole Damm, Johan Rosell and Staffan Jahnson
  Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer
  Scandinavian Journal of Urology and Nephrology, 2008, 42(5), 417-421.
 Web of Science® Times Cited: 2

Jingfang Gao, Gunnar Arbman, L.. He, Zhiyong Zhang, Z. Zhao, Johan Rosell and Xiao-Feng Sun
  MANBA polymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations
 
Altmetric usage: 1

  Acta Oncologica, 2008, 47(3), 372-378.

Katja Fall, Fredrik Strömberg, Johan Rosell and Eberhard Varenhorst
  Reliability of death certificates in prostate cancer patients
  Scandinavian Journal of Urology and Nephrology, 2008, 42(4), 352-357.
 Web of Science® Times Cited: 30

David Robinson, Gunnar Aus, Julia Bak, Tomasz Gorecki, Anders Herder, Johan Rosell and Eberhard Varenhorst
  Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors
  Scandinavian Journal of Urology and Nephrology, 2007, 41(2), 103-109.
 Web of Science® Times Cited: 14

Bo Nordenskjöld, Johan Rosell, Lars-Erik Rutqvist, Per-Olof Malmström, Jonas Bergh, Nils-Olof Bengtsson, Thomas Hatschek, Arne Wallgren and John Carstensen
  Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial
  Journal of the National Cancer Institute, 2005, 97(21), 1609-1610.
 Web of Science® Times Cited: 40

Gunnar Aus, David Robinson, Johan Rosell, Gabriel Sandblom and Eberhard Varenhorst
  Survival in prostate carcinoma - Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: Results from three counties in the population-based National Prostate Cancer Registry of Sweden
  Cancer, 2005, 103(5), 943- 951.
 Web of Science® Times Cited: 33

Gabriel Sandblom, Eberhard Varenhorst, Owe Löfman, Johan Rosell and Per Carlsson
  Clinical consequences of screening for prostate cancer: 15 Years follow-up of a randomised controlled trial in Sweden
  European Urology, 2004, 46(6), 717-723.
 Web of Science® Times Cited: 55

Gunnar Aus, Kerstin Nordenskjöld, David Robinson, Johan Rosell and Eberhard Varenhorst
  Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer: A Prospective Study Based on Data from a Swedish Population-Based Cohort
  European Urology, 2003, 43(6), 627-631.
 Web of Science® Times Cited: 16

Ph.D. Theses

Johan Rosell
  Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer
  2014.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.